Support 100 years of independent journalism.

  1. Science & Tech
  2. Coronavirus
19 May 2020updated 29 Jul 2021 11:20am

Where is the Covid-19 death rate still rising?

By Michael Goodier

Western Europe and the US might have passed the peak of coronavirus, but many countries around the world are still very much fighting a rising tide.

Brazil, Mexico, Russia, Peru, India, Pakistan, and Indonesia have all seen daily death figures rise, when calculated as a seven-day rolling average.

The rise in South America and elsewhere means that global figures are only going down slightly week-on-week, despite big falls in Europe.

In the last seven days, 32,151 people died after testing positive for the disease, according to the latest data from John’s Hopkins University.

That compares to 34,793 over the previous week.

Sign up for The New Statesman’s newsletters Tick the boxes of the newsletters you would like to receive. Quick and essential guide to domestic and global politics from the New Statesman's politics team. The New Statesman’s global affairs newsletter, every Monday and Friday. The best of the New Statesman, delivered to your inbox every weekday morning. A handy, three-minute glance at the week ahead in companies, markets, regulation and investment, landing in your inbox every Monday morning. Our weekly culture newsletter – from books and art to pop culture and memes – sent every Friday. A weekly round-up of some of the best articles featured in the most recent issue of the New Statesman, sent each Saturday. A weekly dig into the New Statesman’s archive of over 100 years of stellar and influential journalism, sent each Wednesday. Sign up to receive information regarding NS events, subscription offers & product updates.
I consent to New Statesman Media Group collecting my details provided via this form in accordance with the Privacy Policy

At least 318,481 people have now died from the disease worldwide.

Covid-19 daily report

Content from our partners
A healthy conversation, a healthy career
A sustainable solution for inhalers
Why modelling matters: its role in future healthcare challenges